Preferential Issue of shares Inter alia consider and approve the following: 1. Proposal for issuance of equity shares/ convertible warrants on preferential basis for raising funds, in accordance with the provisions of the Companies Act, 2013 read with rules made thereunder and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended from time to time, and subject to such regulatory/statutory approvals as may be required, including approval of the shareholders of the Company

Quarterly Results

Inter alia, to consider and approve the following agenda items: 1. To consider and approve the proposed acquisition of a 51% equity stake in M/s. E Trav Tech Limited ("Target Company") through a share swap arrangement by way of a preferential issue of equity shares of the Company, subject to obtaining all requisite statutory, regulatory, contractual, and other approvals, consents, permissions, and compliances as may be required under the applicable laws. 2. Proposal for raising of funds by issuance of equity shares / convertible bonds / debentures / convertible warrants / preference shares or any other equity linked securities ("Securities") through permissible modes including by way of a private placement, including through a preferential issue or qualified institutions placement of Securities or any other method or mode as may be permitted under applicable laws, including the Companies Act, 2013 read with the rules notified thereunder and the Securities and Exchange Board of India (issue of Capital and Disclosure Requirements) Regulations, 2018. 3. To propose alteration, addition, replacement, or deletion of the main object clause of the Company 4. To consider any other business with the permission of the Chairperson.

Quarterly Results

Audited Results & Final Dividend

Inter alia, to consider and approve the following:- 1. The proposal for raising funds by way of a Rights Issue of equity shares to the eligible equity shareholders of the Company for an aggregate amount of up to Rs.50,00,00,000 (Rupees Fifty Crores Only), in accordance with the applicable provisions of the Companies Act, 2013, the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable laws, subject to such statutory and regulatory approvals as may be required. 2. The proposal for increase in the Authorised Share Capital of the Company, if required, to facilitate the proposed Rights Issue and to ensure adequate headroom for issuance of equity shares pursuant thereto. 3. Consequent alteration of the Capital Clause of the Memorandum of Association of the Company and other related documents, if required, subject to the approval of the Board and the shareholders of the Company, as applicable. 4. To determine and approve the detailed terms and conditions of the Rights Issue, including but not limited to the issue size, rights entitlement ratio, issue price, record date, rights issue schedule, appointment of intermediaries, draft Letter of Offer and such other matters incidental or connected therewith. 5. Discussion on Appointment and Resignation of Directors. 6. Any other matter incidental or connected with the proposed Rights Issue and increase in the Authorised Share Capital

Inter alia, among the Subject matter mentioned below: 1. To Propose the Preferential Issue of Equity Shares to the Non-Promoters of the Company not exceeding Rs.30,00,00,000 (Rupees Thirty Crores). 2. To Authorize Mr. Y. Siddharth Reddy, Vice-Chairman & Director and Mr. D. Krishna Kumar Raju, Vice-Chairman & CEO of the Company to lead the proposed issue and appoint the necessary Intermediaries for the proposed issue. 3. Any, other matter with the permission of the Chair.

Quarterly Results

Quarterly Results

Final Dividend

Quarterly Results

Quarterly Results

Stock Split The Board of Directors of Integrated Proteins Limited which was scheduled to be held today, i.e. Friday ,July 3, 2026, is now postponed and re-scheduled to Thursday, July 9, 2026, inter alia to consider and approve Sub-Division (split) of the Equity Shares of the Company subject to approval of shareholders and other regulatory approvals, as may be required and any other business with the permission of the Board.

Inter alia, to consider and approve:- 1. The proposal for alteration of the Objects Clause of the Memorandum of Association of the Company, subject to the approval of shareholders. 2. Such Other agendas as may be considered necessary with the permission of the chair.

Preferential Issue of shares & Inter alia, to consider and evaluate the proposal for the preferential issue of equity shares and/or convertible warrants to the Promoter/Promoter Group for meeting the funding requirements towards the expansion of the Company's lab-grown diamond business, in accordance with the applicable laws, subject to the approval of the members of the Company and such statutory, regulatory and governmental approvals as may be required, and to approve all ancillary matters in connection therewith

Financial Results/Other business matters

Fund Raising/Other business matters

Inter alia, to discuss on the business and operations of the Company.

Inter alia: a) Toconsider and approve the enhancement of the borrowing limits of the Company up to Rs. 200 Crores under Section 180(1)(c) of the Companies Act, 2013. b) To consider and approve the issuance of Secured Non-Convertible Debentures (NCDs) ona private placement basis up to Rs. 25 Crores. c) Toconsider and approve the Notice of Postal Ballot for seeking shareholders approval in respect of the proposed issuance of NCDs ona private placement basis and other matters. d) To consider any other business with the permission of the Chair.

Other business matters

Quarterly Results

Audited Results

Inter alia, to consider and approve and evaluate a proposal for issuance of equity shares or any eligible securities or a combination thereof through a preferential issue on a private placement basis, QIP, rights issue or through any other permissible mode as may be considered appropriate , subject to such regulatory/statutory approvals as may be required including the approval of the members of the Company, and to approve such ancillary actions in relation to the above as may be required.

Audited Results & Interim Dividend

Inter alia, to consider and approve :- 1. To consider & Approved the appointment of Pramod & Associates, Chartered Accountants, as Statutory Auditors, C Scheme, Jaipur, Rajasthan for FY 2026-2027 in place of Amit Ramakant & Company. 2. To consider & Approved the Appointment of Internal Auditor & Fix their remuneration. 3. To consider & Approved the Notice of 20th Annual General Meeting & Annual report including Board Report, Notice of AGM, and all other annexure(s). 4. To consider & Approved the Appointed Mr. Vinod Kumar Naredi, Practicing Company Secretary as Scrutinizer for conducting e-voting Process in the 19th Annual General Meeting. 5. To consider & Approved the Appointment of Ms. Vishakha Saini, as Independent Director of the Company. & A.G.M.